New Advances in Neuro-Oncology

Dear Colleagues,

Tumors of the central nervous system (CNS) encompassing the brain and spinal cord are difficult to treat and often spell poor prognosis for the affected patient. Among the most aggressive CNS tumors are malignant gliomas and CNS-localized metastatic seeds derived from peripheral cancers of the lung, skin, breast, gastrointestinal tract or kidney. Even initially benign brain lesions, such as meningiomas and pituitary adenomas, harbor the potential to progress to an aggressive, life-threatening phenotype. Despite continuous improvements in detection and diagnosis, surgery, radiation treatment, chemotherapies and targeted therapies, and the advent of immune system-targeted interventions, CNS malignancies remain deadly, and too many patients still succumb to these diseases.  

This Special Issue of the Journal of Clinical Medicine on “New Advances in Neuro-Oncology” aims to collect insightful contributions from experts in the field. We invite investigators from around the world to submit original basic science research articles, translational developments, results from clinical studies, and critical review articles that provide up-to-date information and introduce new advances of the entire compendium of neuro-oncology, from experiments at the bench to clinical applications at the bedside.

Prof. Dr. Thomas C. Chen
Dr. Axel H. Schönthal
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• primary brain tumors
• brain metastases
• blood–brain barriermolecular mechanisms
• preclinical models
• novel therapeutics
• migration and invasion
• clinical trials
• tumor microenvironment
• tumor stem cells
• angiogenesis